目的 观察武警某部男性青年官兵幽门螺杆菌(H.pylori, Hp)在上消化道疾病中的感染及耐药情况,指导临床用药。方法 选取2014-06至2015-03间因上消化道疾病在我院内镜室检查的172例青年官兵为研究对象,均经胃镜检查并钳取胃黏膜标本,经Hp培养、分离,采用KB法检测Hp菌株对克拉霉素、甲硝唑、左氧氟沙星、阿莫西林、四环素、呋喃唑酮等抗生素的耐药率。结果 172例标本共84例Hp培养阳性,阳性率为48.8%,32例慢性浅表性胃炎Hp阳性15例,8例慢性非萎缩性胃炎Hp阳性4例,26例糜烂性胃炎Hp阳性12例;41例胃溃疡Hp阳性20例,35例十二指肠溃疡Hp阳性18例,30例复合性溃疡Hp阳性15例。经比较发现,各疾病种类的Hp阳性率差异无统计学意义。84例Hp阳性标本对常用抗生素的耐药率分别为:克拉霉素(31.0%)、甲硝唑(35.7%)、左氧氟沙星(11.9%)、阿莫西林(1.2%)、四环素(1.2%)、呋喃唑酮(0)。结论 青年官兵Hp感染率较高,对阿莫西林、四环素、呋喃唑酮的耐药率低,推荐在Hp根除治疗中首选使用。
Abstract
Objective To observe the Helicobacter pylori (Hp) infection in the upper gastrointestinal tract and its antibiotic resistance in young males of Armed Police Forces in order to facilitate medication .Methods A total of 172 young males of Armed Police Forces with upper gastrointestinal tract diseases were selected between June 2014 and March 2015. Gastric mucosa was clamped via gastroscopes and Hp was cultivated and selected. The KB test was performed to test the susceptibility of clarithromycin, metronidazole, levofloxacin, amoxicillin, tetracycline and furazolidone to Hp. Results 84 strains of Hp were isolated from the gastric mucosa of the 172 cases, and the positive incidence was 48.8%. Hp positiveness was found among 15 of the 32 chronic superficial gastritis patients, , 4 of the 8 chronic non-atrophic gastritis patients, 12 of the 26 erosive gastritis patients, 20 of the 41 gastric ulcer patients, 18 of the 35 cases of duodenal ulcer and among15 of the 18 cases of gastric combined duodenal ulcer. No significant difference was found in the detection rate of Hp between patients with chronic superficial gastritis, chronic non-atrophic gastritis, erosive gastritis, gastric ulcer or duodenal ulcer. The drug susceptibility test indicated that the drug-resistance rate of 84 Hp strains to clarithromycin, metronidazole, levofloxacin, amoxicillin, tetracycline and furazolidone was 31.0%, 35.7%, 11.9%, 1.2%, 1.2%, and 0 respectively. Conclusion Hp has a high infection rate in young males of Armed Police Forces. The drug-resistance to amoxicillin, tetracycline and furazolidone is low, so these drugs should be recommended for use in Hp eradication therapy.
关键词
青年男性 /
幽门螺杆菌 /
耐药性
Key words
young men /
helicobacter pylori /
drug resistance
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 张万岱,胡伏莲,萧树东,等.中国自然人群幽门螺杆菌感染的流行病学调查[J].现代消化及介入诊疗,2010,15(5):265-270.
[2] 苏 鹏,张建中.幽门螺杆菌高耐药流行现状及应对策略[J].中国病原生物学杂志,2013,8(4):368-371,378.
[3] 黎宏章,杨天敢,曾万里,等.浙江省台州地区1030株幽门螺杆菌临床分离株耐药性分析[J].中华流行病学杂志,2011,32(6):636.
[4] Malfertheiner P,Megraud F O,Morain C A,et al. Management ofHelicobacter pylori infection-the MaastrichtIV /Florence ConsensusReport[J].Gut,2012,61(5):646-664.
[5] Kuo S H,Yeh K H,Wu M S,et al. Helicobacter pylori eradication therapy is effective in the treatment of early-stage H. pylori-positive gastric diffuse large B-cell lymphomas[J].Blood,2012,119(21):4838-4844.
[6] 中华医学会消化病学分会幽门螺杆菌学组/全国幽门螺杆菌研究协作组.第四次全国幽门螺杆菌感染处理共识报告[J].中华内科杂志,2012,51(10):832-837.
[7] 李 娜,聂占国.幽门螺旋杆菌对抗生素耐药现状及其机制研究进展[J].山东医药,2013,53(16):85-88.
[8] 马 进,姜 平,马 瑞,等.2009-2011年妇女胃肠炎患者幽门螺杆菌感染现状调查与耐药分析[J].中华医院感染学杂志,2013,23(4):796-798.
[9] 侯中英,崔小强,姜 曼,等.幽门螺杆菌临床治疗中抗菌药物耐药现状及其耐药机制[J].中华实验和临床感染病杂志(电子版),2014,8(4):573-576.
[10] De Francesco V, Giorgio F, Hassan C, et al. Worldwide H.pylori Antibiotic Resistance: a systematic Review[J].J Gastrointestin Liver Dis,2010,19(4):409-414.
[11] 黄德强,罗凌玉,丁士刚,等.204 例幽门螺杆菌耐药情况的分析[J].江西医学院学报,2008,48(1):84-86.
[12] 魏 莉,王林恒,贾 伟,等.比较以阿莫西林和呋喃唑酮为基础的抗幽门螺杆菌四联和三联方案[J].胃肠病学和肝病学杂志,2013,22(8):771-773.